|
|
41
|
|
|
41817
|
|
|
REMICADE 100MG INJ (JAC) INFLIXIMAB (C)
|
|
|
INFLIXIMAB
|
|
|
REMICADE
|
|
|
20ML VIAL
|
|
|
C
|
|
|
1460.17
|
|
|
1460.1749
|
|
|
100MG
|
|
|
VIAL
|
|
|
0
|
|
|
VIAL
|
|
|
JAC
|
|
|
JANSSEN-CILAG
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
9236
|
|
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
DISEASE MODIFYING ANTIRHEUMATIC AGENTS
|
|
|
|